Get started Log in

2160 — GNI Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapNeutral

Market Cap
¥177bn
Enterprise Value
¥185bn
Revenue
¥27bn

2019 group forecast(IFRS)
29/11/2019 06:00
9-MTH group results (IFRS)
14/11/2019 06:00
2019 group forecast(IFRS)
06/09/2019 07:30
6-MTH group results (IFRS)
14/08/2019 07:00
Q1 group results (IFRS)
15/05/2019 08:30
2018 group results (IFRS)
15/05/2019 07:00
2018 group results (IFRS)
14/02/2019 08:20
2018 group forecast(IFRS)
13/02/2019 09:00
9-MTH group results (IFRS)
13/11/2018 07:00
6-MTH group results (IFRS)
14/08/2018 07:00
Q1 group results (IFRS)
11/05/2018 07:01
2017 group results (IFRS)
13/02/2018 06:01
9-MTH group results (IFRS)
10/11/2017 06:00
Brief: GNI Group unit receives marketing approval for Bi-Ostetic Bioactive Glass Foam related product
31/10/2017 09:22
Brief: GNI Group gets IND clearance by FDA for liver fibrosis treatment
09/10/2017 21:00
Brief: GNI Group unit says clearance of IND by FDA for F351 clinical trials in the treatment of liver fibrosis
02/10/2017 02:28
6-MTH group results (IFRS)
10/08/2017 07:01
Brief: GNI Group says exercise of options
18/07/2017 10:03
Brief: GNI Group unit GNI USA to sell stake in IriSys for $3.8 mln and GNI Group to acquire stake in GNI-EPS (HONG KONG) HOLDINGS for $4.2 mln
30/06/2017 07:24
Brief: GNI Group says exercise of options
20/06/2017 08:36